The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
Open accessAbstract
The Coronary Drug Project was conducted between 1966 and 1975 to assess the long-term efficacy and safety of five lipid-influencing drugs in 8,341 men aged 30 to 64 years with electrocardiogram-documented previous myocardial infarction. The two estrogen regimens and dextrothyroxine were discontinued early because of adverse effects. No evidence of efficacy was found for the clofibrate treatment. Niacin treatment showed modest benefit in decreasing definite nonfatal recurrent myocardial infarction but did not decrease total mortality. With a mean follow-up of 15 years, nearly 9 years after termination of the trial, mortality from all causes in each of the drug groups, except for niacin, was similar to that in the placebo group. Mortality in the niacin group was 11% lower than in the placebo group (52.0 versus 58.2%; p = 0.0004). This late benefit of niacin, occurring after discontinuation of the drug, may be a result of a translation into a mortality benefit over subsequent years of the early favorable effect of niacin in decreasing nonfatal reinfarction or a result of the cholesterol-lowering effect of niacin, or both.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical trials using niacin, alone or in combination with other lipid medications, have shown benefits in decreasing cardiovascular event rates and atherosclerosis (173-176).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [174]
In the citing paper
“Currently available outcome data for nicotinic acid from randomized clinical trials are still limited.120,131”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [120]
In the citing paper
“At a daily dose of 2 g it reduces TGs by 20-40% and LDL-C by 15-18% and increases HDL-C by 15-35%.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [257]
In the citing paper
“At a daily dose of 2 g it reduces TGs by 20e40% and LDL-C by 15e18% and increases HDL-C by 15e35%.257,277,278”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [257]
In the citing paper
“Nicotinic acid has been shown to reduce CVD outcomes (194), although the study was done in a nondiabetic cohort.”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [194]
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
(2005) · Technometrics · doi:10.1198/tech.2005.s303 · Cited by 17,923
Bain, L. J. (1967) · Technometrics · doi:10.1080/00401706.1967.10490452 · Cited by 3,407
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Clofibrate and Niacin in Coronary Heart Disease
(1975) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1975.03240160024021 · Cited by 1,747
Self-citationStatistical Methods for Rates and Proportions
Conover, W. J. (1974) · Technometrics · doi:10.1080/00401706.1974.10489195 · Cited by 877
The Coronary Drug Project Research Group (1980) · New England Journal of Medicine · doi:10.1056/nejm198010303031804 · Cited by 659
Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis.
Marvin, H. M. (1964) · Archives of Internal Medicine · doi:10.1001/archinte.1964.00280120106032 · Cited by 384
Research works printed but not linked: 1
- 1973, The Coronary Drug Project: design, methods, and baseline results. (AHA Monograph No. 38.), Circulation, 47, I
Cited by
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Metadata
- Authors
- Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W.
- Affiliations
- Maryland Medical Research Institute (US)
- Corresponding author
- Canner, Paul L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 1986-12
- Volume
- 8
- Issue
- 6
- Pages
- 1245-1255
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2115572248
- Cited by
- 1,824
- References
- 24
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 19 · 2023: 10 · 2022: 15 · 2021: 20 · 2020: 24 · 2019: 25 · 2018: 15 · 2017: 25 · 2016: 47 · 2015: 59 · 2014: 56 · 2013: 72 · 2012: 87
- FWCI
- 70.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 9724 d)
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- nicotinic acid, Coronary Drug Project, long-term mortality, lipid-lowering drugs, reinfarction, secondary prevention, cholesterol lowering, estrogen therapy, dextrothyroxine, clofibrate
- MeSH terms
- Adult, Aspirin, Clofibrate, Dextrothyroxine, Estrogens, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Niacin, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin. https://app.cochat.ai/papers/10.1016/s0735-1097(86)80293-5
- The paper
- Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986). Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(86)80293-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.